Ocular Therapeutix (OCUL) Share-based Compensation (2013 - 2026)
Ocular Therapeutix's quarterly Share-based Compensation came in at $15.6 million in Q1 2026, up 49.02% year-on-year from $10.5 million in Q1 2025, and up 37.18% quarter-over-quarter from $11.4 million in Q4 2025.
Ocular Therapeutix has reported Share-based Compensation for 14 years, with the latest figure at $15.6 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 49.02% year-over-year to $15.6 million; the trailing twelve-month figure through Mar 2026 stood at $48.3 million (up 35.75% YoY), and the FY2025 full-year result was $43.2 million, up 30.43% from the prior year.
- Share-based Compensation for Q1 2026 stood at $15.6 million, up from $11.4 million in the prior quarter.
- The five-year high for Share-based Compensation was $15.6 million in Q1 2026, with the low at $4.2 million in Q1 2022.
- Average Share-based Compensation over 5 years is $7.5 million, with a median of $6.6 million recorded in 2024.
- Year-over-year, Share-based Compensation jumped 155.9% in 2024 and fell 14.3% in 2025.
- Tracing OCUL's Share-based Compensation over 5 years: stood at $4.2 million in 2022, then rose by 2.22% to $4.3 million in 2023, then soared by 66.29% to $7.2 million in 2024, then soared by 57.83% to $11.4 million in 2025, then jumped by 37.18% to $15.6 million in 2026.
- The last three Share-based Compensation figures came in at $15.6 million (Q1 2026), $11.4 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 15.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.58 Mn |
| Mar 31, 2026 | 15.58 Mn |
| Dec 31, 2025 | 11.36 Mn |
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 4.23 Mn |
| Dec 31, 2022 | 4.23 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.84 Mn |
| Dec 31, 2021 | 3.84 Mn |
| Sep 30, 2021 | 3.76 Mn |
| Sep 30, 2021 | 3.76 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Mar 31, 2021 | 3.09 Mn |
| Mar 31, 2021 | 3.09 Mn |
| Dec 31, 2020 | 2.10 Mn |
| Dec 31, 2020 | 2.10 Mn |
| Sep 30, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.94 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Mar 31, 2020 | 1.67 Mn |
| Mar 31, 2020 | 1.67 Mn |
| Dec 31, 2019 | 1.95 Mn |
| Dec 31, 2019 | 1.95 Mn |
| Sep 30, 2019 | 3.17 Mn |
| Sep 30, 2019 | 3.17 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Mar 31, 2019 | 1.94 Mn |
| Mar 31, 2019 | 1.94 Mn |
| Dec 31, 2018 | 1.95 Mn |
| Dec 31, 2018 | 1.95 Mn |
| Sep 30, 2018 | 1.87 Mn |
| Sep 30, 2018 | 1.87 Mn |
| Jun 30, 2018 | 1.83 Mn |
| Jun 30, 2018 | 1.83 Mn |
| Mar 31, 2018 | 1.83 Mn |
| Mar 31, 2018 | 1.83 Mn |
| Dec 31, 2017 | 2.11 Mn |
| Dec 31, 2017 | 2.11 Mn |
| Sep 30, 2017 | 1.75 Mn |
| Sep 30, 2017 | 1.75 Mn |
| Jun 30, 2017 | 1.76 Mn |
| Jun 30, 2017 | 1.76 Mn |
| Mar 31, 2017 | 1.71 Mn |
| Mar 31, 2017 | 1.71 Mn |
| Dec 31, 2016 | 1.72 Mn |
| Dec 31, 2016 | 1.72 Mn |
| Sep 30, 2016 | 1.37 Mn |
| Sep 30, 2016 | 1.37 Mn |
| Jun 30, 2016 | 1.52 Mn |
| Jun 30, 2016 | 1.52 Mn |
| Mar 31, 2016 | 1.35 Mn |
| Mar 31, 2016 | 1.35 Mn |
| Dec 31, 2015 | 1.34 Mn |
| Dec 31, 2015 | 1.34 Mn |
| Sep 30, 2015 | 1.23 Mn |
| Sep 30, 2015 | 1.23 Mn |
| Jun 30, 2015 | 1.15 Mn |
| Jun 30, 2015 | 1.15 Mn |
| Mar 31, 2015 | 921,000.00 |
| Mar 31, 2015 | 921,000.00 |
| Dec 31, 2014 | 280,000.00 |
| Dec 31, 2014 | 280,000.00 |
| Sep 30, 2014 | 607,000.00 |
| Sep 30, 2014 | 607,000.00 |
| Jun 30, 2014 | 557,000.00 |
| Jun 30, 2014 | 557,000.00 |
| Mar 31, 2014 | 503,000.00 |
| Mar 31, 2014 | 503,000.00 |
| Dec 31, 2013 | 125,000.00 |
| Dec 31, 2013 | 125,000.00 |
| Sep 30, 2013 | 121,000.00 |
| Sep 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 121,000.00 |